logo
Plus   Neg
Share
Email

Boston Scientific Stock Up On FDA Approval For LOTUS Edge Aortic Valve System

Boston Scientific Corp.'s (BSX) shares gained around 2 percent in the extended trading on Tuesday after the company announced it has received U.S. Food and Drug Administration approval for the LOTUS Edge Aortic Valve System.

The transcatheter aortic valve replacement or TAVR technology is delivered through a minimally-invasive procedure. The system is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement through open heart surgery.

The company initiated a controlled launch of the valve system in Europe in March, and in the coming weeks it will begin a controlled launch in the U.S.

According to the company, the LOTUS Edge valve system is the only FDA-approved aortic valve that gives physicians the option to reposition and completely recapture the valve once it has been fully deployed.

Boston Scientific shares settled on Tuesday regular trading at $35.89, up 2.75%. In the after hours trading, shares gained 2.06 percent further to $36.63.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT